Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions.
Kührer
I
I
Kuzmits
R
R
Linkesch
W
W
Ludwig
H
H
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007820:Laryngeal Mucosa / Q000473:pathology*; D007830:Larynx / Q000473:pathology*; D010608:Pharyngeal Diseases / Q000188:drug therapy; D011458:Prostaglandins E / Q000008:administration & dosage*; D014456:Ulcer / Q000139:chemically induced / Q000188:drug therapy*; D014623:Vaginal Diseases / Q000188:drug therapy; D014945:Wound Healing / Q000187:drug effects
D000970:Antineoplastic Agents; D011458:Prostaglandins E; D015232:Dinoprostone